1-3 of 3
Gajanan Bhat, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia after Same-Day Dosing of Eflapegrastim in Patients with Breast Cancer Receiving Docetaxel and Cyclophosphamide (NCT04187898)

Lee S. Schwartzberg, MD, Jawad Francis, MD, Hlalah Osama, MD, Manuel Modiano, MD, Jayaram Bharadwaj, MD, Shanta Chawla, MD, Gajanan Bhat, PhD, Francois Lebel, MD FRCPC, Nishan Tchekmedyian, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-134012
Published: 2020
Journal Articles

Results from a Phase 1/2, Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma

Madeleine Duvic, MD, Steven M Horwitz, MD, Youn H Kim, MD, Pier Luigi Zinzani, Gajanan Bhat, PhD, Pankaj Sharma, Sue Yancik
Journal: Blood
Blood (2015) 126 (23): 2677.
https://doi.org/10.1182/blood.V126.23.2677.2677
Published: 2015
Journal Articles

Safe and Effective Treatment of Patients with Peripheral T-Cell Lymphoma (PTCL) with the Novel HDAC Inhibitor, Belinostat, in Combination with CHOP: Results of the Bel-CHOP Phase 1 Trial

Patrick B. Johnston, MD PhD, Amanda F. Cashen, MD, Petros G. Nikolinakos, MD, Anne W Beaven, MD, Stefan Klaus Barta, MDMRCP,MS, Gajanan Bhat, PhD, Tao Song, Mi Rim Choi, MD, Lee F. Allen, MD PhD, Sven de Vos, MD PhD, Yasuhiro Oki, MD, Changchun Deng, MDPhD, Francine M Foss, MD
Journal: Blood
Blood (2015) 126 (23): 253.
https://doi.org/10.1182/blood.V126.23.253.253
Published: 2015